Bleach Clean
Registered User
- Aug 9, 2006
- 27,058
- 6,635
Then you agree with me. Gillis didn't buy low.
Oh I see, you wanted a top6 forward for peanuts in a trade _AND_ you wanted him to have an excellent contract, instead of average?
Then you agree with me. Gillis didn't buy low.
Because in my opinion, he can re sign Higgins and Raymond for basically the same combined price of Booth. We have serious cap issues in the off season.
Trade Booth. Trade Luongo / Schneider. Trade Ballard.
I guess that means you're saying that Booth is the best value in the league when you said the trade was "as buy low as it gets" (insert sarcastic smilie).Oh I see, you wanted a top6 forward for peanuts in a trade _AND_ you wanted him to have an excellent contract, instead of average?
I guess that means you're saying that Booth is the best value in the league when you said the trade was "as buy low as it gets" (insert sarcastic smilie).
I'm saying getting Booth was not buying low. His contract is par for the course, at best. And no where did I say what I wanted from him.
My definition of "buying low" is attaining something perceived incorrectly as having low value or something that has value that can be increased. Booth appears to be neither.
Initially, I was in favour of the trade. In retrospect:
Broken down Samuelsson+washed up Sturm > Booth
In fact, you could argue FLA bought low. They got an old, oft-injured player that wound up producing as well as the player they gave up and they got out of a contract. I know you don't want to discuss contracts but that's a very important point for a team like FLA.
If you think Samuelsson and Sturm was/is worth more than Booth, then I'm not sure what to say to you.
I guess it would be time for me to ask if there are comparable deals where a team gave up less for a 26 year old top6 forward? Is there? Did any go for less within the last 3 years? 5 years?
I'm actually interested to know. My assessment is based on the fact that there hasn't been a comparable value trade within the last 5 years. Maybe there has been?
You're proceeding on the premise that Booth is a top 6 forward. Hansen deserves a spot on the second line more than he does and I don't think Hansen is a second line player.
Isn't Booth in the top 90 of all forwards when you break it down to G/60 or something like that?
Then you agree with me. Gillis didn't buy low.
My definition of "buying low" is attaining something perceived incorrectly as having low value or something that has value that can be increased. Booth appears to be neither.
Samuelsson was worth the same as Booth last year. He and Sturm would have been off the books this year so their value now is irrelevant.
You're proceeding on the premise that Booth is a top 6 forward. Hansen deserves a spot on the second line more than he does and I don't think Hansen is a second line player.
I believe his A/60 is one of the worst in the NHL for top 6 forwards.
You can't refer to Booth as a buy-low player until his value goes up. If that doesn't happen, it's just a trade for a low-value asset. There's a reason no other team outbid our nothing offer, in a league where 20 teams are desperate for more top 6 scoring...
Same goes for Hodgson. People say we sold high but that's obviously not the case. He's much more valuable today than the day he was dealt. Gillis thought he 'built him up', which is concerning considering how much better he is this year than when he was moved.
What's your statistical definition of a top6 player?
Jonathan Willis broke it down as an average of 35 points per 82 games. Meaning top 180 across the league. Do you agree?
Wait, Hodgson's more valuable now? Based on what? His league leading goals against?
If Booth has kept his G/60 ratio while moving to a new situation in VAN, then you don't have to wait for him to improve to call it a buy low option. Make sense?
Also, did you make up that A/60 number or do you have some data? Just curious.
Hodgson is more valuable now because he's producing like a 1st line centre. He's 2nd in the NHL in even strength points. Concerns about his back are also lessened with each passing month.
IMO it's only buy-low if the player improves his value. For example, I don't believe Ballard should be considered a buy-low candidate right now unless he improves on his new team.
As for Booth's A/60, it's just an observation based on looking around the league at other top 6 forwards. It's hard to find guys less productive in top 6 roles...
And Booth has only managed this once in his last 3 years and didn't do it as a Canuck. So by Willis' definition, Booth is not a top 6 forward...
In '12 he was at that pace. In '11 he put up 40 and in '10 he was out with concussion. Where are you gettin your numbers?
To me even if Booth dose not improve from last year, when he was playing on his off side with broken Raymond and broken no pass Kesler, he is still worth more then what we paid for him. In my book if you pay less then what something is worth then its buy low.
But you have to factor in what you're getting for the cap hit too. So far, we've received a 29 point season and a player that hurt himself while doing fitness testing. A far cry from what you want from a guy making north of $4mil.
In a cap environment, it kills you having big ticket players that can't stay healthy. It's just so difficult replacing players through trade and leaves the team in a tough position. If Booth can't stay healthy from now until the end of the playoffs I wouldn't bring him back next season. Too much risk, too little reward.
His pace is irrelevant. Willis didn't give a single other player in the NHL the benefit of the doubt of pace or projection. It would be unfair to give it Booth if we're setting the benchmark at a paltry 35 points.
Pro-rating this season would make Willis' benchmark 20 points for a top 6 forward. Odds are, Booth misses the mark for the 3rd time in 4 years.
But you have to factor in what you're getting for the cap hit too. So far, we've received a 29 point season and a player that hurt himself while doing fitness testing. A far cry from what you want from a guy making north of $4mil.
In a cap environment, it kills you having big ticket players that can't stay healthy. It's just so difficult replacing players through trade and leaves the team in a tough position. If Booth can't stay healthy from now until the end of the playoffs I wouldn't bring him back next season. Too much risk, too little reward.